“Hey, you know, breakdowns come. And breakdowns go. So what are you going to do about it? That’s what I’d like to know – Gumboots
In an era of COVID, political uncertainty, and market volatility, exhibiting resilience and staying true to our values and mission is a tall order. That notwithstanding, the Paul Simon song that our CSO has quoted since we founded Spero had it right. As leaders, we must supersede these challenges to instill resilience on an organizational level to navigate the twists and turns of getting medicines to patients. The value creation of biotech is in part what we’ve planned for, but also (and often more importantly) how we react when the unexpected happens.
By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC.
It is a strange time to work in the biotech industry.
National unemployment has spiked to 11%, the Federal Reserve Bank of Atlanta predicts a 35% drop in US GDP in the second quarter, and yet the XBI index of biotech stocks has risen by more than 20% since the beginning of March, when the pandemic threat became apparent in the US.
Sanofi Pasteur is betting big on its pact with mRNA biotech Translate Bio as it deepens its ties and commitment to infectious disease vaccines using this new tech.
As we approach our 5th anniversary and surpass our 125th hire, we have come to recognize that one of the most important characteristics for success at AVROBIO is a commitment to our mantra of “smart speed.” We’ve been thinking a lot about what that term means for us – and for the field of gene therapy.
By Deanna Petersen, chief business officer at AVROBIO, and Georgette Verdin, chief human resources officer at AVROBIO, as part of the From The Trenches feature of LifeSciVC.
It’s been over three months since stay at home advisories and social distancing protocols abruptly arrived in Massachusetts. Calls for a return to normal and getting “back” to how things once were are growing louder by the day. In recent weeks, protests calling for racial equality and an end to systemic injustice have unfolded across the nation. The disproportionate share of minority populations dying of COVID-19 coupled with recent cases of police brutality, are a catalyst for change that has been long overdue. People are growing restless on every level and for good reason. As business leaders, we have an opportunity to find ways to use this unrest to question the status quo and evaluate where to drive change.
By Jodie Morrison, CEO of Cadent Therapeutics, as part of the From The Trenches feature of LifeSciVC